These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31152162)

  • 41. Vaccine adjuvants: is the pipeline clogged?
    Leitner WW
    Immunotherapy; 2012 Jun; 4(6):565-7. PubMed ID: 22788122
    [No Abstract]   [Full Text] [Related]  

  • 42. Control of vector-borne infectious diseases by human immunity against α-Gal.
    Cabezas Cruz A; Valdés JJ; de la Fuente J
    Expert Rev Vaccines; 2016 Aug; 15(8):953-5. PubMed ID: 27100121
    [No Abstract]   [Full Text] [Related]  

  • 43. Expression library immunization: a road map for discovery of vaccines against infectious diseases.
    Talaat AM; Stemke-Hale K
    Infect Immun; 2005 Nov; 73(11):7089-98. PubMed ID: 16239502
    [No Abstract]   [Full Text] [Related]  

  • 44. [Host tolerance and infectious disease].
    Shinzawa N; Kanuka H
    Seikagaku; 2010 Nov; 82(11):1051-5. PubMed ID: 21226336
    [No Abstract]   [Full Text] [Related]  

  • 45. The European effort towards the development of mucosal vaccines for poverty-related diseases.
    Medaglini D; Olesen OF; Rappuoli R
    Vaccine; 2009 May; 27(20):2641-8. PubMed ID: 19428873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The use of new vaccines by a pediatrician on an individual basis].
    González de Aledo Linos A
    An Esp Pediatr; 1998 Aug; 49(2):212-3. PubMed ID: 9773568
    [No Abstract]   [Full Text] [Related]  

  • 47. Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
    van Riet E; Ainai A; Suzuki T; Kersten G; Hasegawa H
    Adv Drug Deliv Rev; 2014 Jul; 74():28-34. PubMed ID: 24862579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction.
    Mills KH
    Immunol Lett; 2009 Feb; 122(2):108-11. PubMed ID: 19100777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress in computational studies of host-pathogen interactions.
    Zhou H; Jin J; Wong L
    J Bioinform Comput Biol; 2013 Apr; 11(2):1230001. PubMed ID: 23600809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of pathogen genomics in assessing disease transmission.
    Sintchenko V; Holmes EC
    BMJ; 2015 May; 350():h1314. PubMed ID: 25964672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex differences shape the response to infectious diseases.
    Ingersoll MA
    PLoS Pathog; 2017 Dec; 13(12):e1006688. PubMed ID: 29284060
    [No Abstract]   [Full Text] [Related]  

  • 52. Fight or learn to live with the consequences?
    Boots M
    Trends Ecol Evol; 2008 May; 23(5):248-50. PubMed ID: 18374449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomics research: the underpinning of infectious disease prevention and control strategies.
    Malik S
    Public Health Genomics; 2013; 16(1-2):3. PubMed ID: 23548710
    [No Abstract]   [Full Text] [Related]  

  • 54. [Infectious diseases--new horizons].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunology. Flexibility for specificity.
    Davis MM
    Science; 2015 Jan; 347(6220):371-2. PubMed ID: 25613876
    [No Abstract]   [Full Text] [Related]  

  • 56. Systems-level analysis of innate immunity.
    Zak DE; Tam VC; Aderem A
    Annu Rev Immunol; 2014; 32():547-77. PubMed ID: 24655298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cells: Flexibility in humans.
    Kugelberg E
    Nat Rev Immunol; 2015 Jan; 15(1):3. PubMed ID: 25534617
    [No Abstract]   [Full Text] [Related]  

  • 58. Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease.
    MacPherson A; Otto SP; Nuismer SL
    Genetics; 2018 Feb; 208(2):779-789. PubMed ID: 29223971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of being scientifically cautious when criticizing the administration of vaccines: 'retracted' post truth.
    Barry A; Bottasso OA; Vicco MH
    Immunotherapy; 2019 Jan; 11(1):7-9. PubMed ID: 30702008
    [No Abstract]   [Full Text] [Related]  

  • 60. [Progress in assessment of vaccine on herd protection].
    Jin PF; Li JX; Zhu FC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):862-866. PubMed ID: 29936762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.